Patents by Inventor Gudrun Claus-Herz

Gudrun Claus-Herz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8883221
    Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: November 11, 2014
    Assignee: Bausch & Lomb Incorporated
    Inventors: Guenter Bellmann, Gudrun Claus-Herz
  • Publication number: 20080260859
    Abstract: A composition comprises at least an omega-3 fatty acid, at least an omega-6 fatty acid, and zinc. The composition is advantageously administered to a subject suffering from a condition of dry eye. In certain embodiment, the amount of omega-3 fatty acid is much higher than that of the omega-6 fatty acid.
    Type: Application
    Filed: October 11, 2005
    Publication date: October 23, 2008
    Inventors: Gudrun Claus-Herz, Guenther Bellmann
  • Publication number: 20080014287
    Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.
    Type: Application
    Filed: December 17, 2004
    Publication date: January 17, 2008
    Inventors: Guenter Bellmann, Gudrun Claus-Herz
  • Publication number: 20040071778
    Abstract: Ophthalmic composition with prolonged residence time on the eye, in particular in the form of a gel which can be administered as drops, of an ointment or the like, containing a free-flowing vehicle with increased viscosity and a preservative, and, where appropriate, one or more active ingredients and conventional additives such as tonicity agents, substances to adjust the pH etc. The preservative is essentially formed according to the invention by a benzyllauryldimethylammonium salt. The invention furthermore relates to the use of a benzyllauryldimethylammonium salt as preservative for producing ophthalmic compositions intended for repeated use over lengthy periods and/or formulated for a lengthy residence time on the eye after each use, whereby irritation and/or damage to the tissue of the eye are avoided.
    Type: Application
    Filed: July 23, 2003
    Publication date: April 15, 2004
    Applicant: Bausch & Lomb Incorporated
    Inventors: Gunther Bellmann, Gudrun Claus-Herz
  • Publication number: 20040063678
    Abstract: The invention relates to an ophthalmological preparation containing dexamethasone as the active ingredient and, optionally, also containing the usual additives and water, which is characterized by a content of at least one gel-forming pharmacologically acceptable substance in a quantity sufficient for adjusting the viscosity of the preparation as a gel.
    Type: Application
    Filed: September 18, 2003
    Publication date: April 1, 2004
    Applicant: Bausch & Lomb Incorporated
    Inventors: Gunther Bellmann, Gudrun Claus-Herz, Christoph Kessler
  • Patent number: 6610318
    Abstract: The invention relates to a sterile ophthalmic drop preparation, especially a gel preparation, which comprises a two-phase carrier liquid or gel basis comprising a liquid aqueous and a liquid hydrophobic phase.
    Type: Grant
    Filed: January 11, 1999
    Date of Patent: August 26, 2003
    Assignee: Bausch & Lomb Incorporated
    Inventors: Gunther Bellmann, Gudrun Claus-Herz, Cornelia Reimer Hevia
  • Patent number: 6605295
    Abstract: The invention relates to stable ophthalmic preparations including the penetrant antiphlogistic diclofenac or salts thereof and the penetrant antibiotic ofloxacin present in the form of the racemate, an enantiomer, particularly levofloxacin, or the corresponding hydrochloride thereof. The preparations may be used for treating eye infections and/or inflammations and for preventing infections before and after eye surgery.
    Type: Grant
    Filed: March 20, 2000
    Date of Patent: August 12, 2003
    Assignee: Bausch & Lomb Incorporated
    Inventors: Gunther Bellmann, Gudrun Claus-Herz, Christoph Kessler
  • Patent number: 6599944
    Abstract: Ophthalmic composition with prolonged residence time on the eye, in particular in the form of a gel which can be administered as drops, of an ointment or the like, containing a free-flowing vehicle with increased viscosity and a preservative, and, where appropriate, one or more active ingredients and conventional additives such as tonicity agents, substances to adjust the pH etc. The preservative is essentially formed according to the invention by a benzyllauryldimethylammonium salt. The invention furthermore relates to the use of a benzyllauryldimethylammonium salt as preservative for producing ophthalmic compositions intended for repeated use over lengthy periods and/or formulated for a lengthy residence time on the eye after each use, whereby irritation and/or damage to the tissue of the eye are avoided.
    Type: Grant
    Filed: May 19, 2000
    Date of Patent: July 29, 2003
    Assignee: Bausch & Lomb Incorporated
    Inventors: Gunther Bellmann, Gudrun Claus-Herz
  • Publication number: 20030077302
    Abstract: The present invention relates to ophthalmic compositions in the form of suspension gels of the free acid of the diclofenamide for treating glaucoma. The invention also relates to the use of suspension gels containing the free acid of the diclofenamide for treating primary and/or secondary open-angle glaucomas, for reducing the intra-ocular pressure and for treating ocular hypertension.
    Type: Application
    Filed: September 30, 2002
    Publication date: April 24, 2003
    Inventors: Gudrun Claus-Herz, Gunther Bellmann